Effect of subtherapeutic antimicrobials on genetic diversity of Enterococcus faecium from chickens

Avian Diseases
Charlene R JacksonCharles L Hofacre

Abstract

The effect of growth promotants (bacitracin, virginiamycin, and flavomycin) on the genetic population of Enterococcusfaecium isolated from a commercially integrated poultry farm was examined. A total of 551 E. faecium were isolated from chick boxliners (n=16), litter (n=334), feed (n=67), and carcass rinse (n=134) samples from four chicken houses. Two houses on the farm were control houses and did not use any antimicrobials while two other houses on the farm used flavomycin, virginiamycin, and bacitracin during six different chicken grow outs. BOX-PCR and pulsed-field gel electrophoresis (PFGE) results indicated that E. faecium strains had a high degree of genetic diversity as overall clustering was independent of source, house, or grow out. Similarity of > or =60% for the majority of BOX-PCR genogroups and > or =80% for the majority of PFGE genogroups was observed for a subset of carcass rinse samples (n=45) examined. Seventy-nine percent (19/24) of isolates in BOX-PCR genogroup 2 also clustered in PFGE genogroup 2, although no association between the isolates and house or grow out was observed. These results suggest that E. faecium from chicken are genetically diverse and that growth-promoting antimicrobials do not affect the...Continue Reading

References

Apr 1, 1989·Journal of Clinical Microbiology·R R Facklam, M D Collins
May 1, 1987·Reviews of Infectious Diseases·H L DuPont, J H Steele
Jan 7, 1998·Journal of Applied Microbiology·R H Gustafson, R E Bowen
Mar 28, 1998·Antimicrobial Agents and Chemotherapy·L A WeltonM J Zervos
Aug 19, 2000·The Journal of Infectious Diseases·R J WillemsJ D van Embden
Nov 4, 2000·Journal of Clinical Microbiology·D TurabelidzeA Sulakvelidze
Jan 4, 2001·International Journal of Antimicrobial Agents·W Witte
Mar 2, 2002·Applied and Environmental Microbiology·Marc VancanneytWilhelm H Holzapfel
Apr 25, 2002·Proceedings of the National Academy of Sciences of the United States of America·David L SmithJ Glenn Morris
May 2, 2002·Proceedings of the National Academy of Sciences of the United States of America·Marc LipsitchBruce R Levin
May 31, 2002·Journal of Clinical Microbiology·Wieger L HomanRob J L Willems
Nov 11, 2003·Journal of Microbiological Methods·Susan DonabedianMarcus Zervos
Dec 6, 2003·The Journal of Antimicrobial Chemotherapy·Ian PhillipsJohn Waddell
Jul 9, 2004·Applied and Environmental Microbiology·Charlene R JacksonScott R Ladely
Aug 7, 2004·Journal of Clinical Microbiology·Charlene R JacksonJohn B Barrett
Aug 25, 2004·International Journal of Antimicrobial Agents·L KellyJ G Morris

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis
PCR

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.